Ella Foundation on Monday announced that it has successfully completed preliminary studies to develop a vaccine for the Ebola virus, which has claimed hundreds of lives in West Africa.

The Hyderabad-based foundation said it had completed the preliminary animal experiments of the virus’ glycoprotein with the targeted adenovirus. Claiming that the results of animal experiments were good, Ella Foundation founder director Krishna Ella said these would be followed by pre-clinical toxicology and then clinical trials in humans.

He said Ebola vaccine programme initiated in November last year was an expression of solidarity and the pledge by the Indian prime minister to help the West African nations with their fight against Ebola virus. According to the World Health Organisation,the current outbreak of Ebola has claimed more than 10,000 lives. The foundation earlier helped Bharat Biotech to develop of H1N1 pandemic influenza in the early stage.

Ella Foundation, a not-for-profit research organization, is among the two foundations from the Asian region which won the Gates Foundation Grand Challenges Explorations (GCE) grant, an initiative funded by the Bill & Melinda Gates Foundation to foster innovation in global health research.

Related Posts

Hospital funded by Tompolo shut down.

Strike: UBTH now engages private firm to perform Lab. tests.

3000 Cross River residents receive free eye treatment.

Health Group Solicits Media Partnership.

Health Worker gets Lassa fever, 2 Lassa patients abscond in Kaduna, North west Nigeria

South Africa launches HIV plans for sex workers.

No Comments

Leave a Comment

Visit Us On TwitterVisit Us On FacebookVisit Us On YoutubeCheck Our Feed